亚太类器官市场预测至 2030 年 – 区域分析 – 按器官类型（肠、肝、胃、胰腺、肺、脑、肾等）、应用（生物疾病的发展、传染病的病理学、再生）药品、药物发现和个性化医疗、药物毒性和功效测试等）、来源（多能干细胞和器官特异性成体干细胞）和类型（仪器、消耗品和服务）
No. of Pages: 98 | Report Code: TIPRE00018852 | Category: Life Sciences
No. of Pages: 98 | Report Code: TIPRE00018852 | Category: Life Sciences
对新药和先进药物的需求不断增长正在推动药物发现和研究的整体步伐。据 ClinicalTrials.gov 统计，2020 年临床试验研究总数估计为 356,282 项。休布雷希特研究所最近的一项调查表明，类器官可以通过识别不太可能从该药物中受益的患者来使昂贵的药物更具成本效益。全球范围内越来越多的临床试验预计将推动对包括类器官模型在内的先进医疗技术的需求。
此外，药物发现中的类器官不仅限于癌症，它们也用于其他疾病，如囊性纤维化、多囊肾病、小头畸形以及肠道和气道感染性疾病。例如，类器官可以概括器官的特性，例如器官结构和功能。此外，类器官可以恢复组织或器官的原始遗传和表观遗传状态，使它们适合基因编辑。各种研究显示了将 CRISPR-Cas9 技术与类器官相结合的积极成果，这为囊性纤维化的突破提供了更多机会。根据一项研究“基于 CRISPR 的腺嘌呤编辑器纠正囊性纤维化类器官生物库中的无义突变”， 2020 年发表的囊性纤维化肠道类器官生物库包含 664 名患者，其中约 20% 理论上能够通过腺嘌呤碱基编辑器有效修复囊性纤维化跨膜导体受体中的无义突变。尽管基因编辑类器官在一些动物模型中取得了一些成果，但其效率明显较低，成功率不高。因此，研究和开发基因编辑类器官的安全性、长期稳定性和功能性的工艺至关重要。
此外，COVID-19大流行引发了需要开发人类肺类器官模型。例如，MilliporeSigma 开发了 3dGRO 人肺类器官培养系统，使研究人员能够控制、访问和复制器官组织，以培养人肺上皮类器官模型，从而有助于在研究过程中获得积极和成功的结果。因此，此类创新预计将为市场增长提供更重要的增长机会。
亚太地区类器官市场分为澳大利亚、中国、印度、日本、韩国和亚太地区其他地区。由于癌症发病率上升、对基因突变和癌症研究的需求不断增长、政府努力提高对人类类器官的认识、支持性法规等因素，该地区的市场在预测期内可能会继续以最快的速度增长用于先进人类类器官产品的开发和商业化，并增加对类器官研究的资助。
亚太类器官市场细分为;器官类型、类型应用、来源和国家/地区。
根据器官类型，亚太类器官市场分为肠、肝、胃、胰腺、肺、脑、肾等。 2022 年，肠道细分市场在亚太类器官市场中占据最大份额。
根据类型，亚太类器官市场分为仪器、消耗品和服务。 2022年，消耗品领域在亚太类器官市场中占据最大份额。
根据应用，亚太类器官市场分为发育生物学疾病、传染病病理学、再生医学、药物毒性和功效测试、药物发现和个性化医疗等。到2022年，发育生物学疾病领域在亚太类器官市场中占据最大份额。
根据来源，亚太类器官市场分为多能干细胞和器官特异性类器官成体干细胞。到 2022 年，多能干细胞细分市场在亚太类器官市场中占据更大份额。
根据国家/地区，亚太类器官市场分为日本、中国、澳大利亚、印度、韩国和亚太其他地区。 2022 年，日本在亚太类器官市场占据主导地位。
Cellesce、Corning Inc、InSphero、Merck KGaA、STEMCELL Technologies Inc 和 Thermo Fisher Scientific Inc 是运营中的一些领先公司亚太类器官市场。
Strategic insights for Asia Pacific Organoids involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 341.24 Million |
| Market Size by 2030 | US$ 1,866.32 Million |
| Global CAGR (2022 - 2030) | 23.7% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By 器官类型
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Organoids refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Organoids Market is valued at US$ 341.24 Million in 2022, it is projected to reach US$ 1,866.32 Million by 2030.
As per our report Asia Pacific Organoids Market, the market size is valued at US$ 341.24 Million in 2022, projecting it to reach US$ 1,866.32 Million by 2030. This translates to a CAGR of approximately 23.7% during the forecast period.
The Asia Pacific Organoids Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Organoids Market report:
The Asia Pacific Organoids Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Organoids Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Organoids Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Organoids Market
